)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
Cosciens Biopharma
Cosciens Biopharma (CSCI) investor relations material
Cosciens Biopharma AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary17 Jun, 2026
Opening remarks and agenda
Meeting opened with introductions of the board and explanation of virtual meeting procedures, including Q&A and voting protocols.
Agenda included presentation of financial statements, auditor appointment, board elections, and a special resolution on share consolidation and split.
Board and executive committee updates
Six directors were nominated for re-election, all confirmed their willingness to serve and were eligible under corporate bylaws.
Shareholder proposals
Special resolution proposed for a share consolidation (1 for 150) followed by a share split (50 for 1), with cash-out for holders of fewer than 150 shares at $1.60 per share.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Cosciens Biopharma
- Returned to profitability in Q1 2026, driven by discontinued operations and lower expenses.CSCI
Q1 202612 May 2026 - Restructuring and subsidiary exit drove lower losses and improved cost structure in 2025.CSCIQ4 202525 Mar 2026
- Six directors elected, auditor reappointed, and company name change approved; no questions asked.CSCIAGM 20243 Feb 2026
- Operating expenses fell 59% and net loss narrowed in Q3 2025 amid restructuring and Nasdaq delisting.CSCIQ3 202512 Nov 2025
- Q2 2025 saw revenue growth, cost cuts, Nasdaq delisting, and major leadership changes.CSCIQ2 202514 Aug 2025
- Q3 2024 net loss widened on higher R&D and merger costs; new product launches on track.CSCIQ3 202413 Jun 2025
- Revenue rose but net loss widened due to higher R&D and SG&A costs; DETECT trial data expected Q3.CSCIQ2 202413 Jun 2025
- Revenue up 35% but net loss deepened as COSCIENS pivots to natural-based products.CSCIQ4 20246 Jun 2025
- Net loss widened in Q1 2025 as COSCIENS advanced clinical and nutraceutical initiatives.CSCIQ1 20256 Jun 2025
Next Cosciens Biopharma earnings date
Q2 202612 Aug, 2026
Cosciens Biopharma
Next Cosciens Biopharma earnings date
Q2 202612 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage